Cortical gyrification a possible early biomarker for PD progression
Researchers have found reductions in cortical gyrifications in patients with newly diagnosed Parkinson’s disease that worsen over time and may therefore serve as a potential biomarker for disease progression.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
